PARP12-mediated mono-ADP-ribosylation as a checkpoint for necroptosis and apoptosis
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2426660122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Xin Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201203, Ch…. Hauptthemen laut MEDLINE: Necroptosis, Apoptosis, Poly(ADP-ribose) Polymerases, ADP-Ribosylation. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Necroptosis and apoptosis are two alternatively regulated cell death pathways. Activation of RIPK1 upon engagement of TNFR1 by TNFα may promote necroptosis by interacting with RIPK3 or apoptosis by activating caspases. RIPK1 is extensively regulated by a variety of dynamic posttranslational modifications which control its kinase activity and formation of downstream complexes to mediate necroptosis and apoptosis. Here, we investigate the functional significance and mechanism by which PARP12, a mono-ADP-ribosyltransferase, interacts with RIPK1 and RIPK3 in cells stimulated by IFNγ and TNFα. We show that PARP12 catalyzes the mono-ADP-ribosylation (MARylation) of RIPK1 in both the intermediate domain and the kinase domain, as well as the MARylation of RIPK3. PARP12 deficiency reduces necroptosis by inhibiting the activation of RIPK1 kinase and its interaction with RIPK3, as well as sensitizes to apoptosis by promoting the binding of RIPK1 with caspase-8. Thus, upon induction by IFNs, PARP12 may function as a cellular checkpoint that controls RIPK1 to promote necroptosis and inhibit apoptosis. Importantly, while PARP12 is a known interferon-stimulated gene (ISG), PARP12 deficiency promotes the expression of a subset of ISGs and confers protection against influenza A virus-induced mortality in mice. Our study demonstrates that PARP12 is an important modulator of cellular antiviral response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201203, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- Shanghai Key Laboratory of Aging Studies, Shanghai 201210, China.
- Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai 200031, China.
ORCID-Profile: Junying Yuan
Zitieren
APA
Huang, X., Li, F., Liu, L., Li, Y., Zhang, M., Ma, G., Gao, Y., Shan, B., Liang, X., Yuan, J., & Pan, H. (2025). PARP12-mediated mono-ADP-ribosylation as a checkpoint for necroptosis and apoptosis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2426660122
Vancouver
Huang X, Li F, Liu L, Li Y, Zhang M, Ma G, et al. PARP12-mediated mono-ADP-ribosylation as a checkpoint for necroptosis and apoptosis. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2426660122
BibTeX
@article{Huang2025,
author = {Huang, Xin and Li, Fangxia and Liu, Lin and Li, Yanxia and Zhang, Mengmeng and Ma, Guoming and Gao, Ying and Shan, Bing and Liang, Xiaozhen and Yuan, Junying and Pan, Heling},
title = {PARP12-mediated mono-ADP-ribosylation as a checkpoint for necroptosis and apoptosis},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2426660122}
}
EUVIMED